RMD
Price
$263.03
Change
+$11.62 (+4.62%)
Updated
Feb 4 closing price
Capitalization
38.32B
77 days until earnings call
Intraday BUY SELL Signals
SMTI
Price
$20.74
Change
+$0.19 (+0.92%)
Updated
Feb 4 closing price
Capitalization
185.33M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RMD vs SMTI

Header iconRMD vs SMTI Comparison
Open Charts RMD vs SMTIBanner chart's image
ResMed
Price$263.03
Change+$11.62 (+4.62%)
Volume$1.73M
Capitalization38.32B
Sanara MedTech
Price$20.74
Change+$0.19 (+0.92%)
Volume$97.49K
Capitalization185.33M
RMD vs SMTI Comparison Chart in %
RMD
Daily Signal:
Gain/Loss:
SMTI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RMD vs. SMTI commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a StrongBuy and SMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (RMD: $263.03 vs. SMTI: $20.74)
Brand notoriety: RMD and SMTI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RMD: 172% vs. SMTI: 190%
Market capitalization -- RMD: $38.32B vs. SMTI: $185.33M
RMD [@Pharmaceuticals: Other] is valued at $38.32B. SMTI’s [@Pharmaceuticals: Other] market capitalization is $185.33M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 0 FA rating(s) are green whileSMTI’s FA Score has 0 green FA rating(s).

  • RMD’s FA Score: 0 green, 5 red.
  • SMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 6 TA indicator(s) are bullish while SMTI’s TA Score has 3 bullish TA indicator(s).

  • RMD’s TA Score: 6 bullish, 4 bearish.
  • SMTI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RMD is a better buy in the short-term than SMTI.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а +2.06% price change this week, while SMTI (@Pharmaceuticals: Other) price change was -2.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -1.97%, and the average quarterly price growth was +23.00%.

Reported Earning Dates

RMD is expected to report earnings on Apr 23, 2026.

SMTI is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($38.3B) has a higher market cap than SMTI($185M). RMD YTD gains are higher at: 9.200 vs. SMTI (-11.178). RMD has higher annual earnings (EBITDA): 2B vs. SMTI (4.78M). RMD has more cash in the bank: 1.38B vs. SMTI (14.9M). SMTI has less debt than RMD: SMTI (47.4M) vs RMD (846M). RMD has higher revenues than SMTI: RMD (5.26B) vs SMTI (102M).
RMDSMTIRMD / SMTI
Capitalization38.3B185M20,703%
EBITDA2B4.78M41,918%
Gain YTD9.200-11.178-82%
P/E Ratio26.02N/A-
Revenue5.26B102M5,154%
Total Cash1.38B14.9M9,289%
Total Debt846M47.4M1,785%
FUNDAMENTALS RATINGS
RMD vs SMTI: Fundamental Ratings
RMD
SMTI
OUTLOOK RATING
1..100
1461
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
3699
PRICE GROWTH RATING
1..100
5783
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (37) in the Medical Specialties industry is somewhat better than the same rating for SMTI (87) in the null industry. This means that RMD’s stock grew somewhat faster than SMTI’s over the last 12 months.

RMD's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as SMTI (100) in the null industry. This means that RMD’s stock grew similarly to SMTI’s over the last 12 months.

RMD's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for SMTI (99) in the null industry. This means that RMD’s stock grew somewhat faster than SMTI’s over the last 12 months.

RMD's Price Growth Rating (57) in the Medical Specialties industry is in the same range as SMTI (83) in the null industry. This means that RMD’s stock grew similarly to SMTI’s over the last 12 months.

RMD's P/E Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for SMTI (100) in the null industry. This means that RMD’s stock grew somewhat faster than SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RMDSMTI
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signal:
Gain/Loss:
SMTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WVMDF1.52N/A
+0.23%
West Vault Mining Inc.
HUBV0.11N/A
N/A
Hubb Ventures Inc.
MNTHF4.40N/A
N/A
Minth Group, Ltd.
PYTCF3.63N/A
N/A
Playtech PLC
SDZXF76.75-1.68
-2.14%
Sandoz Group AG

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BLFS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+4.62%
BLFS - RMD
44%
Loosely correlated
-0.74%
SMTI - RMD
43%
Loosely correlated
+0.92%
SOLV - RMD
40%
Loosely correlated
+0.98%
RVTY - RMD
40%
Loosely correlated
+2.67%
SYK - RMD
39%
Loosely correlated
-0.04%
More

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with NXGL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then NXGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
+0.92%
NXGL - SMTI
57%
Loosely correlated
-0.81%
ZJYL - SMTI
56%
Loosely correlated
+1.45%
STVN - SMTI
48%
Loosely correlated
+1.00%
A - SMTI
47%
Loosely correlated
+0.64%
NVST - SMTI
46%
Loosely correlated
+3.27%
More